/EIN News/ — CONSHOHOCKEN, PA, July 11, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – NextEvo Naturals (“NextEvo” or the “Company”), a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, announced today early results from the successful completion of a prospective study on its groundbreaking water-soluble cannabidiol (CBD) oral formulation. The study, which focused on safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) immune response biomarkers, represents a significant milestone in advancing the understanding of CBD’s potential benefits.
Over a three-day period, NextEvo Naturals’ novel CBD formulation was tested at two concentrations consumed at twice daily intervals. Rapidly achieving steady-state blood levels with twice-daily consumption, the formulation demonstrated excellent tolerability and safety, with no serious adverse events reported even at the higher concentration tested.
One of the most compelling findings of the study was the significant modulation LPS-stimulated whole blood cytokines assays(TruCulture, RBM), highlighting the potential immunomodulatory effects of NextEvo Naturals’ CBD formulation. Serum cytokine levels also exhibited immunomodulatory effects that were concentration dependent, suggesting the need for further exploration in optimizing CBD preparations and personalized consumption strategies for immune effects….
Original Author Link click here to read complete story..
